Nlife Therapeutics

Oligonucleotide-based therapies for Parkinsons's disease and other CNS disorders

placeArmilla, Andalusia, Spain calendar_todayFounded 2010 groups17 employees language n-life.es

Innovation

7 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 540 times.

YearFilings
20122
20131
20142
20154
20162
20172
20183
20191
20211

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital4100%
Coming soon